Wedbush Securities’s Amicus Therapeutics FOLD Stock Holding History

Wedbush Securities’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,456	Closed	-$166K	–	1332
2026 Q1	$166K	Buy	+11,456	New	+$164K	﹤0.01%	1162

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wedbush Securities's FOLD Position: Q2 2026 in Review

Wedbush Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 11,456 shares — an estimated $166K sold.

Wedbush Securities first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $166K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Wedbush Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Wedbush Securities sold 11,456 Amicus Therapeutics shares in Q2 2026, an estimated $166K.
Wedbush Securities first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Wedbush Securities's Amicus Therapeutics position peaked at $166K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.